NTLA Sale Disclosure
Dube Michael P · SEC Form 4 · Filed Oct 6, 2026
Sale
Calculated transaction value
$23.17K
Dube Michael P VP, Chief Accounting Officer
NTLA
Transaction date
Oct 2, 2026
Public filing date
Oct 6, 2026
Filing lag
Filed 4 days later
NTLA daily price context
Close on/before transaction
$12.26
Oct 2, 2026
First close after public filing
$11.71
Oct 7, 2026
Return after filing · so far
+1.71%
Through Oct 13, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,864 shares @ $12.43
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-415541
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$23.17K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Intellia Therapeutics, Inc. NTLA Current | Sale | Oct 2, 2026 | $23.17K |